{"url_path":"/sec/qucy/8-k/2026-05-18/item-5-02","section_key":"item-5-02","section_title":"Item 5.02 ** **Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-18","source_url":"https://www.sec.gov/Archives/edgar/data/1874252/0001213900-26-058427-index.html","accession_number":"0001213900-26-058427","cik":"0001874252","ticker":"QUCY","issuer_name":"Quantum Cyber N.V.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1874252/0001213900-26-058427-index.html","primary_entity_key":"0001874252","primary_entity_name":"Quantum Cyber N.V."},"word_count":426,"has_tables":true,"body_markdown":"**Item 5.02** **Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**\n\n \n\n*Appointment of Director*\n\n \n\nEffective as of May 13, 2026, to fill vacancy\nin the composition of the Board of Directors (the “Board”), the Board of the Company appointed Peter O’Rourke to serve\nas a director until the annual general meeting of the Company to be held in 2027 or until Mr. O’Rourke’s successor is duly\nelected and qualified, or his earlier death, resignation or removal. Mr. O’Rourke has not yet been appointed to serve on any committee\nof the Board. Mr. O’Rourke will receive the Company’s standard compensation for non-employee directors, which is described\nin the Company’s Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on March 25, 2026.\n\n \n\nPeter O’Rourke has served as a director\nof the Board since May 2026. Mr. O’Rourke has served as Managing Partner at TCI Partners, a consulting firm focused on healthcare,\naerospace and the public sector, from December 2018 to present. From November 2020-July 2022, Mr. O’Rourke was President and Director\nfor Western Magnesium Corporation where he created the U.S. operations strategy and team during the technology pilot phase of the company,\nand led enterprise and defense business development, government affairs, and communications. From January 2017 to December 2018, Mr. O’Rourke\nserved as the Acting Secretary and Chief of Staff of the Department of Veteran Affairs. From May 2015 to July 2016, Mr. O’Rourke\nserved as a principal of Calibre Systems, Inc., a consulting firm. Mr. O’Rourke also served in both the U.S. Navy and Air Force.\nFrom June 2021 to July 2025 Mr. O’Rourke served as the Chairman of the Board of Directors for NorthView Acquisition Corporation.\nSince July 2025, Mr. O’Rourke has been the Lead Independent Director and Chairman of the Nominations and Governance Committee of\nProFusa, Inc., and he has served as Director for AXIM Biotechnologies from July 2020 to present. Mr. O’Rourke received a Bachelor\nof Arts in Political Science from the University of Tennessee in Knoxville as well as a Master of Science in Logistics and Supply Chain\nManagement from the United States Air Force’s Institute of Technology.\n\n \n\nThere are no arrangements or understandings between\nMr. O’Rourke and any other person pursuant to which Mr. O’Rourke was named a director of the Company. Mr. O’Rourke does\nnot have any direct or indirect material interest in any transaction or proposed transaction required to be reported under Item 404(a)\nof Regulation S-K promulgated under the Securities Act of 1933, as amended."}